Daniela Panciera, Royal Surrey NHS FT
I am a Brazilian physicist with a master's degree in radiation protection and have completed a multidisciplinary residency programme in medical physics, specialising in nuclear medicine.
In 2023, I joined the Royal Surrey NHS Foundation Trust as a research scientist and later achieved HCPC registration as a clinical scientist through the international route. In my current role as dosimetry lead physicist, I work alongside medical physics experts (MPEs) to support the delivery of molecular radiotherapy (MRT) and provide medical physics support to external centres. Overall, my work includes patient-specific dosimetry, clinical software validation, image processing, uncertainty analysis, and the optimisation of dosimetry workflows for radionuclide therapies.
Alongside my clinical role, I am the joint project coordinator for the UK Internal Dosimetry Users Group (IDUG), where I also support the development of dosimetry training programmes. In addition, I have been nominated as co-lead of Working Group 4 within the European RATIONALE project, focusing on theragnostic dosimetry.
Anne-Marie Stapleton, Royal Surrey NHS FT
Anne-Marie Stapleton is a Consultant Clinical Scientist and Deputy Head of Nuclear Medicine Physics (Therapeutics) at Royal Surrey NHS Foundation Trust. A registered Medical Physics Expert, she has played a leading role in the implementation and expansion of Lu-177 PSMA therapy services across the NHS and independent sector, supporting the growth of therapeutic nuclear medicine services in the UK.
Alongside her clinical and strategic leadership responsibilities, Anne-Marie is actively involved in national professional groups, including the IPEM Nuclear Medicine Specialist Interest Group and the BNMS Molecular Radiotherapy Consortium, and she chairs a national Lu-177 working group.
Anne-Marie's own career journey has been shaped by alternative professional routes. She trained as a Clinical Scientist through the Route 2 pathway, obtained Medical Physics Expert status through portfolio assessment, and achieved Higher Specialist Scientist registration via the equivalence route. Drawing on these experiences, she is a strong advocate for flexible training pathways and workforce development, and is committed to helping future generations of scientists navigate rewarding careers in nuclear medicine.
Helen Blundell, University of the West of England